201 related articles for article (PubMed ID: 25099078)
1. Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.
O'Neill SC; Mays D; Patenaude AF; Garber JE; DeMarco TA; Peshkin BN; Schneider KA; Tercyak KP
J Community Genet; 2015 Jan; 6(1):55-62. PubMed ID: 25099078
[TBL] [Abstract][Full Text] [Related]
2. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
3. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.
Mays D; DeMarco TA; Luta G; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Tercyak KP
Health Psychol; 2014 Aug; 33(8):765-73. PubMed ID: 23795707
[TBL] [Abstract][Full Text] [Related]
4. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
Demarco TA; Nusbaum RH; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Tercyak KP
Patient Educ Couns; 2010 Jan; 78(1):29-33. PubMed ID: 19545972
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
[TBL] [Abstract][Full Text] [Related]
7. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
[TBL] [Abstract][Full Text] [Related]
8. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
9. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
Tercyak KP; Peshkin BN; Streisand R; Lerman C
Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
[TBL] [Abstract][Full Text] [Related]
10. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
[TBL] [Abstract][Full Text] [Related]
11. Creating opportunities for parent empowerment: program effects on the mental health/coping outcomes of critically ill young children and their mothers.
Melnyk BM; Alpert-Gillis L; Feinstein NF; Crean HF; Johnson J; Fairbanks E; Small L; Rubenstein J; Slota M; Corbo-Richert B
Pediatrics; 2004 Jun; 113(6):e597-607. PubMed ID: 15173543
[TBL] [Abstract][Full Text] [Related]
12. Parent-child factors and their effect on communicating BRCA1/2 test results to children.
Tercyak KP; Peshkin BN; DeMarco TA; Brogan BM; Lerman C
Patient Educ Couns; 2002 Jun; 47(2):145-53. PubMed ID: 12191538
[TBL] [Abstract][Full Text] [Related]
13. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
Tercyak KP; Demarco TA; Mars BD; Peshkin BN
Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
[TBL] [Abstract][Full Text] [Related]
14. Anticipation in hereditary breast cancer.
Dagan E; Gershoni-Baruch R
Clin Genet; 2002 Aug; 62(2):147-50. PubMed ID: 12220452
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.
Staton AD; Kurian AW; Cobb K; Mills MA; Ford JM
Fam Cancer; 2008; 7(2):179-86. PubMed ID: 18026853
[TBL] [Abstract][Full Text] [Related]
16. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Rosenberg SM; Ruddy KJ; Tamimi RM; Gelber S; Schapira L; Come S; Borges VF; Larsen B; Garber JE; Partridge AH
JAMA Oncol; 2016 Jun; 2(6):730-6. PubMed ID: 26867710
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
20. Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
Halbert CH; Stopfer JE; McDonald J; Weathers B; Collier A; Troxel AB; Domchek S
J Clin Oncol; 2011 Nov; 29(32):4302-6. PubMed ID: 21990416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
